BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 21796494)

  • 1. Research and technology in neurocritical care.
    Wijman CA; Smirnakis SM; Vespa P; Szigeti K; Ziai WC; Ning MM; Rosand J; Hanley DF; Geocadin R; Hall C; Le Roux PD; Suarez JI; Zaidat OO;
    Neurocrit Care; 2012 Feb; 16(1):42-54. PubMed ID: 21796494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research priorities in neurocritical care.
    Geocadin RG; Bleck TP; Koroshetz WJ; Robertson CS; Zaidat OO; LeRoux PD; Wijman CA; Suarez JI
    Neurocrit Care; 2012 Feb; 16(1):35-41. PubMed ID: 21792752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first Neurocritical Care Research Conference: a great starting point.
    Suarez JI; LeRoux PD
    Neurocrit Care; 2012 Feb; 16(1):4-5. PubMed ID: 21786044
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurocritical care nursing research priorities.
    Olson DM; McNett MM; Livesay S; Le Roux PD; Suarez JI; Bautista C
    Neurocrit Care; 2012 Feb; 16(1):55-62. PubMed ID: 21786045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Future of "Omics" in Hypertension.
    Currie G; Delles C
    Can J Cardiol; 2017 May; 33(5):601-610. PubMed ID: 28161100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Future of Neurocritical Care Research: Proceedings and Recommendations from the Fifth Neurocritical Care Research Network Conference.
    Hocker S; Shah S; Vespa P; Provencio JJ; Calvillo E; Olson DM; Venkatasubba Rao CP; Hemphill JC; Helbok R; Human T; Kamel H; Madden LK; Nyquist P; Bentho O; O'Phelan K; Lewin JJ; Alexander S; Ziai W; Chou SH; Rincon F; McNett M; Ko N; Zink B; Rhoney D; Diringer MN; Stevens R; Robertson CS; Sampaio G; Shutter LA; Ling G; Rehman M; Mahmoud SH; Yeager S; Livesay S; Suarez JI;
    Neurocrit Care; 2020 Feb; 32(1):311-316. PubMed ID: 31264070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.
    Le Roux P; Menon DK; Citerio G; Vespa P; Bader MK; Brophy GM; Diringer MN; Stocchetti N; Videtta W; Armonda R; Badjatia N; Böesel J; Chesnut R; Chou S; Claassen J; Czosnyka M; De Georgia M; Figaji A; Fugate J; Helbok R; Horowitz D; Hutchinson P; Kumar M; McNett M; Miller C; Naidech A; Oddo M; Olson D; O'Phelan K; Provencio JJ; Puppo C; Riker R; Robertson C; Schmidt M; Taccone F
    Neurocrit Care; 2014 Dec; 21 Suppl 2(Suppl 2):S1-26. PubMed ID: 25208678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome in neurocritical care: advances in monitoring and treatment and effect of a specialized neurocritical care team.
    Suarez JI
    Crit Care Med; 2006 Sep; 34(9 Suppl):S232-8. PubMed ID: 16917428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurocritical care research network: NCRN.
    Suarez JI; Geocadin R; Hall C; Le Roux PD; Smirnakis S; Wijman CA; Zaidat OO
    Neurocrit Care; 2012 Feb; 16(1):29-34. PubMed ID: 21792751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and development of biomarkers of neurological disease.
    Dunckley T; Coon KD; Stephan DA
    Drug Discov Today; 2005 Mar; 10(5):326-34. PubMed ID: 15749281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Omics Data Can Be Used in Nephrology.
    Rhee EP
    Am J Kidney Dis; 2018 Jul; 72(1):129-135. PubMed ID: 29478865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OMICS insights into cancer histology; Metabolomics and proteomics approach.
    Tayanloo-Beik A; Sarvari M; Payab M; Gilany K; Alavi-Moghadam S; Gholami M; Goodarzi P; Larijani B; Arjmand B
    Clin Biochem; 2020 Oct; 84():13-20. PubMed ID: 32589887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical care research networks experience.
    Le Roux PD; Cooper J; Guntupalli KK; Silbergleit R; Daily J; Geocadin R; Wijman CA; Suarez JI
    Neurocrit Care; 2012 Feb; 16(1):20-8. PubMed ID: 21796493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variation and Response to Neurocritical Illness: a Powerful Approach to Identify Novel Pathophysiological Mechanisms and Therapeutic Targets.
    Acosta JN; Brown SC; Falcone GJ
    Neurotherapeutics; 2020 Apr; 17(2):581-592. PubMed ID: 31975153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technologies for biomarker discovery in multiple sclerosis.
    Comabella M; Racke MK
    J Neuroimmunol; 2012 Jul; 248(1-2):1. PubMed ID: 22726889
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of severe hemodynamic disturbances between dexmedetomidine and propofol for sedation in neurocritical care patients.
    Erdman MJ; Doepker BA; Gerlach AT; Phillips GS; Elijovich L; Jones GM
    Crit Care Med; 2014 Jul; 42(7):1696-702. PubMed ID: 24717468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future is now? Clinical and translational aspects of "Omics" technologies.
    D'Adamo GL; Widdop JT; Giles EM
    Immunol Cell Biol; 2021 Feb; 99(2):168-176. PubMed ID: 32924178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric neurocritical care.
    Murphy S
    Neurotherapeutics; 2012 Jan; 9(1):3-16. PubMed ID: 22183817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the most of "omics" for symbiosis research.
    Chaston J; Douglas AE
    Biol Bull; 2012 Aug; 223(1):21-9. PubMed ID: 22983030
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.